Recently, the US Food and Drug Administration (FDA) released six updated or new forms for companies to use when submitting new tobacco product applications through the Pre-Market Tobacco Product Application (PMTA) and Substantial Equivalence (SE) pathways. Starting from July 6, 2025, applicants must use these new forms to submit PMTA or SE reports. Failure to use the latest version of the forms or to fill them out properly may result in the FDA rejecting the application.
The FDA stated that the updated form took into account public input and is one of the important measures taken by the FDA to improve the efficiency, effectiveness, and transparency of the review process. The new version of the form provides updated instructions for filling out the form and more details, clarifying the information applicants need to provide. This will help applicants submit higher quality applications, thereby speeding up the FDA's review process.
Here is the updated list of tables.
Updated PMTA form:
FDA Form 4057 - Pre-market Tobacco Product Application (PMTA) Submission Form
FDA Form 4057a - Pre-market Application Revision and General Communication Submission Form.
FDA Form 4057b – PMTA New Tobacco Product Unique Identifier Information (formerly known as "Grouping Form")
Updated or new SE form:
FDA Form 3965 - Tobacco Product Substantial Equivalence Report Submission Form.
FDA Form 3965a - Revision of the Substantive Equivalence Report and General Communication Submission Form (formerly FDA Form 3964)
FDA Form 3965b (new) – Unique Identifier Information Form for SE New Tobacco Products
To assist applicants in correctly filling out FDA forms 4057b and 3965b, the FDA has also released the Product Form Validator Tool 2.0. Applicants can use this tool to validate the data in both forms to ensure that the information provided meets FDA's acceptance criteria.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
